These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30427714)

  • 41. Medical management of canine hyperinsulinism.
    Nelson RW; Foodman MS
    J Am Vet Med Assoc; 1985 Jul; 187(1):78-82. PubMed ID: 3894306
    [No Abstract]   [Full Text] [Related]  

  • 42. Two cases of canine insulinoma.
    Midoro K; Nakayama H; Okada N; Ono K; Yasuda K; Sawa K; Takahashi R; Fujiwara K
    Nihon Juigaku Zasshi; 1987 Dec; 49(6):1151-3. PubMed ID: 2828736
    [No Abstract]   [Full Text] [Related]  

  • 43. Preliminary evaluation of serial (18) FDG-PET/CT to assess response to toceranib phosphate therapy in canine cancer.
    Leblanc AK; Miller AN; Galyon GD; Moyers TD; Long MJ; Stuckey AC; Wall JS; Morandi F
    Vet Radiol Ultrasound; 2012; 53(3):348-57. PubMed ID: 22360684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Scintigraphic diagnosis of insulinoma in a dog.
    Lester NV; Newell SM; Hill RC; Lanz OI
    Vet Radiol Ultrasound; 1999; 40(2):174-8. PubMed ID: 10225531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of toceranib phosphate (Palladia) monotherapy on multidrug resistant lymphoma in dogs.
    Yamazaki H; Miura N; Lai YC; Takahashi M; Goto-Koshino Y; Yasuyuki M; Nakaichi M; Tsujimoto H; Setoguchi A; Endo Y
    J Vet Med Sci; 2017 Jul; 79(7):1225-1229. PubMed ID: 28592719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic properties of toceranib phosphate (Palladia, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors.
    Yancey MF; Merritt DA; Lesman SP; Boucher JF; Michels GM
    J Vet Pharmacol Ther; 2010 Apr; 33(2):162-71. PubMed ID: 20444041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful treatment of a metastatic, gastrointestinal stromal tumour in a dog with toceranib phosphate (Palladia).
    Elliott JW; Swinbourne F; Parry A; Baines L
    J Small Anim Pract; 2017 Jul; 58(7):416-418. PubMed ID: 28199021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood glucose monitoring during surgery in dogs to assess completeness of surgical resection of insulinoma: 11 cases.
    Collgros NC; Bray JP
    J Am Vet Med Assoc; 2022 Oct; 261(2):229-236. PubMed ID: 36288205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.
    de Vos J; Ramos Vega S; Noorman E; de Vos P
    Vet Comp Oncol; 2012 Sep; 10(3):206-13. PubMed ID: 22236048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New therapeutic options for metastatic malignant insulinomas.
    de Herder WW; van Schaik E; Kwekkeboom D; Feelders RA
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):277-84. PubMed ID: 21649688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence of postoperative complications and outcome of 48 dogs undergoing surgical management of insulinoma.
    Del Busto I; German AJ; Treggiari E; Romanelli G; O'Connell EM; Batchelor DJ; Silvestrini P; Murtagh K
    J Vet Intern Med; 2020 May; 34(3):1135-1143. PubMed ID: 32212400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcome after surgical management of canine insulinoma in 49 cases.
    Cleland NT; Morton J; Delisser PJ
    Vet Comp Oncol; 2021 Sep; 19(3):428-441. PubMed ID: 32558184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma.
    Laver T; London CA; Vail DM; Biller BJ; Coy J; Thamm DH
    Vet Comp Oncol; 2018 Mar; 16(1):E23-E29. PubMed ID: 28621057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.
    Robat C; London C; Bunting L; McCartan L; Stingle N; Selting K; Kurzman I; Vail DM
    Vet Comp Oncol; 2012 Sep; 10(3):174-83. PubMed ID: 22235914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of advanced-stage canine nasal carcinomas with toceranib phosphate: 23 cases (2015-2020).
    Merino-Gutierrez V; Borrego JF; Puig J; Hernández A; Clemente-Vicario F
    J Small Anim Pract; 2021 Oct; 62(10):881-885. PubMed ID: 34131916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs.
    Heaton CM; Fernandes AFA; Jark PC; Pan X
    J Vet Intern Med; 2020 Mar; 34(2):873-881. PubMed ID: 31977135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A retrospective study of proteinuria in dogs receiving toceranib phosphate.
    Piscoya SL; Hume KR; Balkman CE
    Can Vet J; 2018 Jun; 59(6):611-616. PubMed ID: 29910474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
    Myers NC; Andrews GA; Chard-Bergstrom C
    Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulinoma in a dog with pre-existing insulin-dependent diabetes mellitus.
    Bryson ER; Snead EC; McMillan C; MacDougall L; Allen AL
    J Am Anim Hosp Assoc; 2007; 43(1):65-9. PubMed ID: 17209088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual-phase computed tomographic angiography in three dogs with pancreatic insulinoma.
    Mai W; Cáceres AV
    Vet Radiol Ultrasound; 2008; 49(2):141-8. PubMed ID: 18418994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.